000 | 02176 a2200589 4500 | ||
---|---|---|---|
005 | 20250516061149.0 | ||
264 | 0 | _c20120427 | |
008 | 201204s 0 0 eng d | ||
022 | _a1873-3476 | ||
024 | 7 |
_a10.1016/j.ijpharm.2011.10.003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJi, Xiufeng | |
245 | 0 | 0 |
_aNanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance. _h[electronic resource] |
260 |
_bInternational journal of pharmaceutics _cJan 2012 |
||
300 |
_a390-7 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xchemistry |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aDrug Resistance, Multiple |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 |
_aGlycerol _xanalogs & derivatives |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLipids _xchemistry |
650 | 0 | 4 | _aLiposomes |
650 | 0 | 4 |
_aLung Neoplasms _xmetabolism |
650 | 0 | 4 | _aNanotechnology |
650 | 0 | 4 |
_aPaclitaxel _xchemistry |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 |
_aPoloxamer _xchemistry |
650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
650 | 0 | 4 |
_aRhodamine 123 _xmetabolism |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aStearic Acids _xchemistry |
650 | 0 | 4 |
_aSurface-Active Agents _xchemistry |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aGao, Yu | |
700 | 1 | _aChen, Lingli | |
700 | 1 | _aZhang, Zhiwen | |
700 | 1 | _aDeng, Yihui | |
700 | 1 | _aLi, Yaping | |
773 | 0 |
_tInternational journal of pharmaceutics _gvol. 422 _gno. 1-2 _gp. 390-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2011.10.003 _zAvailable from publisher's website |
999 |
_c21234223 _d21234223 |